BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹37 Cr | ₹51 Cr | ₹43 Cr | ₹29 Cr | ₹45 Cr |
What is the latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹51 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹29 Cr |
| Mar2021 | ₹45 Cr |
How is Total Non-Current Liabilities of BLISS GVS PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | -27.20 | |
| Mar2024 | ₹51 Cr | 19.52 | |
| Mar2023 | ₹43 Cr | 46.71 | |
| Mar2022 | ₹29 Cr | -35.46 | |
| Mar2021 | ₹45 Cr | - | |
Compare Total Non-Current Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,163.6 Cr | 1% | 15.9% | 73.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 1% |
15.9% |
73.9% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses